+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
H.Pylori Recombinant Antigen Market - Global Forecast 2026-2032- Product Image
H.Pylori Recombinant Antigen Market - Global Forecast 2026-2032- Product Image
Sale

H.Pylori Recombinant Antigen Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6148971
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The H.Pylori Recombinant Antigen Market is projected to reach USD 124.10 Million in 2026. It is expected to continue growing at a CAGR of 7.69%, reaching USD 193.50 Million by 2032.

H. pylori Recombinant Antigens Support More Specific Diagnostic Development

H. pylori recombinant antigens are engineered proteins used in immunoassays and related diagnostic applications to detect immune responses associated with Helicobacter pylori infection. Their value lies in reproducible composition, targeted antigen selection, and compatibility with standardized laboratory workflows. Development priorities center on analytical specificity, sensitivity, stability, manufacturability, and relevance across genetically diverse H. pylori strains.

Diagnostic Practice Is Shifting Toward Standardization and Better Clinical Fit

The landscape is being reshaped by wider use of noninvasive testing, greater emphasis on confirming eradication after treatment, and demand for assays that perform consistently across laboratories. Recombinant antigen platforms can help reduce variability associated with crude bacterial extracts, while multiplex formats and improved quality controls support more informative testing. Developers must also account for regional differences in strain diversity, disease prevalence, laboratory infrastructure, and clinical guidelines.

Artificial Intelligence Can Improve Antigen Selection, Assay Design, and Quality Control

Artificial intelligence can support epitope discovery, sequence comparison, cross-reactivity assessment, and prioritization of antigen combinations using genomic and immunological datasets. Machine-learning tools may also assist with image interpretation, laboratory-result classification, stability prediction, and detection of manufacturing deviations. These applications remain dependent on representative training data, transparent validation, human oversight, and compliance with medical-device and diagnostic regulations; AI should strengthen, not replace, analytical and clinical verification.

Regional Conditions Shape Adoption of Recombinant Antigen Technologies

North America combines advanced laboratory capacity with strong attention to clinical validation, regulatory documentation, and post-treatment testing. Europe emphasizes harmonized quality requirements while accommodating differences among national healthcare systems. Asia-Pacific presents diverse needs, including high-burden settings, expanding diagnostic infrastructure, and substantial strain heterogeneity. Latin America is influenced by uneven access, public-health priorities, and the need for affordable decentralized testing. The Middle East shows varied laboratory capabilities and referral patterns, with demand shaped by healthcare modernization. Africa requires solutions suited to resource-constrained environments, reliable supply, and practical sample-to-answer workflows.

International Groupings Reveal Different Regulatory and Access Priorities

ASEAN markets require adaptable approaches because regulatory pathways, laboratory capacity, and reimbursement conditions vary across member states. BRICS countries span substantial differences in disease burden, manufacturing capability, and public-sector procurement, making localization and affordability important. The European Union benefits from shared regulatory architecture but still faces national differences in implementation and purchasing. G7 markets generally prioritize evidence quality, cybersecurity where digital tools are used, and integration with established clinical pathways. GCC countries often combine centralized procurement with rapidly developing healthcare infrastructure. NATO members represent a broad set of health systems in which supply resilience, interoperability, and diagnostic preparedness can influence adoption.

Country-Level Priorities Differ Across Established and Emerging Diagnostic Systems

Australia emphasizes quality assurance and geographically accessible testing. Brazil and Mexico must balance affordability, public-health reach, and regional laboratory disparities. Canada and the United States place strong weight on validation, regulatory compliance, and integration with established diagnostic networks. China and India combine substantial clinical need with expanding domestic laboratory and manufacturing capabilities. France, Germany, Italy, Spain, and the United Kingdom operate within mature European diagnostic environments, while differing in procurement and implementation practices. Japan and South Korea emphasize analytical rigor, workflow efficiency, and advanced laboratory automation. Russia’s requirements are shaped by healthcare-system structure, local supply considerations, and regulatory conditions.

Leaders Should Prioritize Evidence, Resilience, and Clinical Workflow Integration

Industry leaders should first define the intended use clearly, then select recombinant antigens against clinically relevant strains and validate performance with diverse specimens. Quality systems should address lot consistency, impurity control, stability, traceability, and documentation from expression through finished assay. Partnerships with reference laboratories and healthcare providers can improve clinical evidence and implementation design. Product strategies should include formats appropriate for centralized and decentralized settings, transparent interpretation guidance, and supply-chain contingencies. AI initiatives should be governed by documented validation, bias testing, data security, and ongoing performance monitoring.

Research Methodology Combines Market-Structure Analysis With Diagnostic Evidence Review

This executive summary uses a structured review of the H. pylori recombinant antigen domain, focusing on antigen biology, diagnostic applications, technology development, regulatory considerations, regional healthcare conditions, and country-level implementation factors. Insights are synthesized from established scientific and clinical knowledge, public regulatory principles, and comparative assessment of laboratory workflows. The analysis intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific claims. Regional, group, and country observations are presented as qualitative context rather than quantified rankings.

Recombinant Antigens Offer a Foundation for More Consistent H. pylori Testing

The field is progressing toward diagnostics that are more standardized, clinically actionable, and adaptable to different healthcare environments. Recombinant antigen selection, rigorous validation, manufacturing control, and responsible use of AI will determine whether new assays deliver reliable results across populations. Success will depend not only on technical performance, but also on affordability, regulatory readiness, laboratory fit, and sustained access across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. H.Pylori Recombinant Antigen Market, by Expression System
7.1. Introduction
7.2. Bacterial
7.2.1. Bacillus
7.2.2. E Coli
7.3. Insect
7.3.1. High-5 Cells
7.3.2. Sf9 Cells
7.4. Mammalian
7.4.1. Cho Cells
7.4.2. Hek293 Cells
7.5. Yeast
7.5.1. Pichia
7.5.2. Saccharomyces
8. H.Pylori Recombinant Antigen Market, by Purity Grade
8.1. Introduction
8.2. Clinical Grade
8.3. Gmp Grade
8.4. Research Grade
9. H.Pylori Recombinant Antigen Market, by End User
9.1. Introduction
9.2. Academic Laboratories
9.3. Diagnostics Companies
9.4. Pharmaceutical Companies
9.5. Research Institutes
10. H.Pylori Recombinant Antigen Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.3. Quality Control
10.4. Research Use Only
10.5. Vaccine Development
11. H.Pylori Recombinant Antigen Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Online Platforms
12. H.Pylori Recombinant Antigen Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. H.Pylori Recombinant Antigen Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. H.Pylori Recombinant Antigen Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abcam plc
16.2. Bio-Rad Laboratories, Inc.
16.3. Biomerica, Inc.
16.4. Boster Biological Technology
16.5. Creative Diagnostics
16.6. DiaSorin S.p.A.
16.7. Enzo Life Sciences, Inc.
16.8. F. Hoffmann-La Roche AG
16.9. GenWay Biotech, Inc.
16.10. Hycult Biotechnology
16.11. ImmunoDiagnostics
16.12. Luminex Corporation
16.13. Mabtech
16.14. Merck KGaA
16.15. Novozymes A/S
16.16. Thermo Fisher Scientific Inc.
16.17. ThermoFisher Diagnostics
16.18. ViroMed Co., Ltd.
16.19. Wako Pure Chemical Industries, Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global H.Pylori Recombinant Antigen Market, Years Considered for the Study
FIGURE 2. Global H.Pylori Recombinant Antigen Market, Research Design
FIGURE 3. Global H.Pylori Recombinant Antigen Market, Research Framework
FIGURE 4. Global H.Pylori Recombinant Antigen Market, Data Triangulation
FIGURE 5. Global H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
FIGURE 6. Global H.Pylori Recombinant Antigen Market Size, by Expression System, 2025 vs 2032 (%)
FIGURE 7. Global H.Pylori Recombinant Antigen Market Size, by Expression System, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2025 vs 2032 (%)
FIGURE 9. Global H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global H.Pylori Recombinant Antigen Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global H.Pylori Recombinant Antigen Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global H.Pylori Recombinant Antigen Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global H.Pylori Recombinant Antigen Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global H.Pylori Recombinant Antigen Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global H.Pylori Recombinant Antigen Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global H.Pylori Recombinant Antigen Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global H.Pylori Recombinant Antigen Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global H.Pylori Recombinant Antigen Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global H.Pylori Recombinant Antigen Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global H.Pylori Recombinant Antigen Market Segmentation & Coverage
TABLE 2. Global H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 3. Global H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 4. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Bacillus Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Bacillus Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Bacillus Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global E Coli Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global E Coli Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global E Coli Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Insect Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Insect Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Insect Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global High-5 Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global High-5 Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global High-5 Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Sf9 Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Sf9 Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Sf9 Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Mammalian Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Mammalian Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Mammalian Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Cho Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Cho Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Cho Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Hek293 Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Hek293 Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Hek293 Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Yeast Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Yeast Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Yeast Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Pichia Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Pichia Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Pichia Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Saccharomyces Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Saccharomyces Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Saccharomyces Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 41. Global Clinical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Clinical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Clinical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Gmp Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Gmp Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Gmp Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Research Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Research Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Research Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 51. Global Academic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Academic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Academic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Diagnostics Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Diagnostics Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Diagnostics Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Quality Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Research Use Only Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Research Use Only Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Research Use Only Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Vaccine Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Vaccine Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Vaccine Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 77. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Online Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Online Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Online Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global H.Pylori Recombinant Antigen Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific H.Pylori Recombinant Antigen Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. North America H.Pylori Recombinant Antigen Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. North America H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 99. North America H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 100. North America H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 101. North America H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 102. North America H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 103. North America H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 104. North America H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. North America H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. North America H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 107. Latin America H.Pylori Recombinant Antigen Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Latin America H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 109. Latin America H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 110. Latin America H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 111. Latin America H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 112. Latin America H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 113. Latin America H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 114. Latin America H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Latin America H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. Latin America H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. Europe H.Pylori Recombinant Antigen Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Europe H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 119. Europe H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 120. Europe H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 121. Europe H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 122. Europe H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 123. Europe H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 124. Europe H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. Europe H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. Europe H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. Middle East H.Pylori Recombinant Antigen Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Middle East H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 129. Middle East H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 130. Middle East H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 131. Middle East H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 132. Middle East H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 133. Middle East H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 134. Middle East H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. Middle East H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. Middle East H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. Africa H.Pylori Recombinant Antigen Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Africa H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 139. Africa H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 140. Africa H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 141. Africa H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 142. Africa H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 143. Africa H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 144. Africa H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Africa H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. Africa H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. Global H.Pylori Recombinant Antigen Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. ASEAN H.Pylori Recombinant Antigen Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. ASEAN H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 150. ASEAN H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 151. ASEAN H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 152. ASEAN H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 153. ASEAN H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 154. ASEAN H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 155. ASEAN H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. ASEAN H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. ASEAN H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 158. GCC H.Pylori Recombinant Antigen Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. GCC H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 160. GCC H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 161. GCC H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 162. GCC H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 163. GCC H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 164. GCC H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 165. GCC H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. GCC H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. GCC H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 168. European Union H.Pylori Recombinant Antigen Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. European Union H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 170. European Union H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 171. European Union H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 172. European Union H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 173. European Union H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 174. European Union H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 175. European Union H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. European Union H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. European Union H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. BRICS H.Pylori Recombinant Antigen Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. BRICS H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 180. BRICS H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 181. BRICS H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 182. BRICS H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 183. BRICS H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 184. BRICS H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 185. BRICS H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. BRICS H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. BRICS H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. G7 H.Pylori Recombinant Antigen Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. G7 H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 190. G7 H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 191. G7 H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 192. G7 H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 193. G7 H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 194. G7 H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 195. G7 H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. G7 H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. G7 H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 198. NATO H.Pylori Recombinant Antigen Market Size, by Group, 2017-2032 (USD Million)
TABLE 199. NATO H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 200. NATO H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 201. NATO H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 202. NATO H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 203. NATO H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 204. NATO H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 205. NATO H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. NATO H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 207. NATO H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. Global H.Pylori Recombinant Antigen Market Size, by Country, 2017-2032 (USD Million)
TABLE 209. United States H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 210. United States H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 211. United States H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 212. United States H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 213. United States H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 214. United States H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 215. United States H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 216. United States H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. United States H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. United States H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. Canada H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 220. Canada H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 221. Canada H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 222. Canada H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 223. Canada H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 224. Canada H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 225. Canada H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 226. Canada H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Canada H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. Canada H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 229. Mexico H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 230. Mexico H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 231. Mexico H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 232. Mexico H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 233. Mexico H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 234. Mexico H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 235. Mexico H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 236. Mexico H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. Mexico H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. Mexico H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 239. Brazil H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 240. Brazil H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 241. Brazil H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 242. Brazil H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 243. Brazil H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 244. Brazil H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 245. Brazil H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 246. Brazil H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. Brazil H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. Brazil H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 249. United Kingdom H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 250. United Kingdom H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 251. United Kingdom H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 252. United Kingdom H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 253. United Kingdom H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 254. United Kingdom H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 255. United Kingdom H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 256. United Kingdom H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. United Kingdom H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. United Kingdom H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 259. Germany H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 260. Germany H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 261. Germany H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 262. Germany H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 263. Germany H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 264. Germany H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 265. Germany H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 266. Germany H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. Germany H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. Germany H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 269. France H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 270. France H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 271. France H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 272. France H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 273. France H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 274. France H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 275. France H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 276. France H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. France H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. France H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 279. Russia H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 280. Russia H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 281. Russia H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 282. Russia H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 283. Russia H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 284. Russia H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 285. Russia H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 286. Russia H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. Russia H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 288. Russia H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 289. Italy H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 290. Italy H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 291. Italy H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 292. Italy H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 293. Italy H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 294. Italy H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 295. Italy H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 296. Italy H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. Italy H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. Italy H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 299. Spain H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 300. Spain H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 301. Spain H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 302. Spain H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 303. Spain H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 304. Spain H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 305. Spain H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 306. Spain H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. Spain H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. Spain H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 309. China H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 310. China H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 311. China H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 312. China H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 313. China H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 314. China H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 315. China H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 316. China H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. China H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 318. China H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 319. India H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 320. India H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 321. India H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 322. India H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 323. India H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 324. India H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 325. India H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 326. India H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 327. India H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 328. India H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 329. Japan H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 330. Japan H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 331. Japan H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 332. Japan H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 333. Japan H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 334. Japan H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 335. Japan H.Pylori Recombinant Antigen Market Size, by Purity Grade, 2017-2032 (USD Million)
TABLE 336. Japan H.Pylori Recombinant Antigen Market Size, by End User, 2017-2032 (USD Million)
TABLE 337. Japan H.Pylori Recombinant Antigen Market Size, by Application, 2017-2032 (USD Million)
TABLE 338. Japan H.Pylori Recombinant Antigen Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 339. Australia H.Pylori Recombinant Antigen Market Size, 2017-2032 (USD Million)
TABLE 340. Australia H.Pylori Recombinant Antigen Market Size, by Expression System, 2017-2032 (USD Million)
TABLE 341. Australia H.Pylori Recombinant Antigen Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 342. Australia H.Pylori Recombinant Antigen Market Size, by Insect, 2017-2032 (USD Million)
TABLE 343. Australia H.Pylori Recombinant Antigen Market Size, by Mammalian, 2017-2032 (USD Million)
TABLE 344. Australia H.Pylori Recombinant Antigen Market Size, by Yeast, 2017-2032 (USD Million)
TABLE 345. Australia H.Pylori Recombinant Antigen Market Size, by Purity Grad

Companies Mentioned

  • Abcam plc
  • Bio-Rad Laboratories, Inc.
  • Biomerica, Inc.
  • Boster Biological Technology
  • Creative Diagnostics
  • DiaSorin S.p.A.
  • Enzo Life Sciences, Inc.
  • F. Hoffmann-La Roche AG
  • GenWay Biotech, Inc.
  • Hycult Biotechnology
  • ImmunoDiagnostics
  • Luminex Corporation
  • Mabtech
  • Merck KGaA
  • Novozymes A/S
  • Thermo Fisher Scientific Inc.
  • ThermoFisher Diagnostics
  • ViroMed Co., Ltd.
  • Wako Pure Chemical Industries, Ltd.

Related Topics

Related Reports

Helicobacter Pylori Non-invasive Testing Market - Global Forecast 2026-2032 - Product Image

Helicobacter Pylori Non-invasive Testing Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Non-invasive Helicobacter Pylori Diagnostic Market - Global Forecast 2026-2032 - Product Image

Non-invasive Helicobacter Pylori Diagnostic Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Non-invasive Helicobacter Pylori Testing - Global Strategic Business Report - Product Image

Non-invasive Helicobacter Pylori Testing - Global Strategic Business Report

  • Report
  • 176 Pages
  • Global
From
Helicobacter Pylori Diagnostics - Global Strategic Business Report - Product Image

Helicobacter Pylori Diagnostics - Global Strategic Business Report

  • Report
  • 249 Pages
  • Global
From
Helicobacter Pylori Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Helicobacter Pylori Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.